The gut microbiota and host health: a new clinical frontier
- PMID: 26338727
- PMCID: PMC4752653
- DOI: 10.1136/gutjnl-2015-309990
The gut microbiota and host health: a new clinical frontier
Abstract
Over the last 10-15 years, our understanding of the composition and functions of the human gut microbiota has increased exponentially. To a large extent, this has been due to new 'omic' technologies that have facilitated large-scale analysis of the genetic and metabolic profile of this microbial community, revealing it to be comparable in influence to a new organ in the body and offering the possibility of a new route for therapeutic intervention. Moreover, it might be more accurate to think of it like an immune system: a collection of cells that work in unison with the host and that can promote health but sometimes initiate disease. This review gives an update on the current knowledge in the area of gut disorders, in particular metabolic syndrome and obesity-related disease, liver disease, IBD and colorectal cancer. The potential of manipulating the gut microbiota in these disorders is assessed, with an examination of the latest and most relevant evidence relating to antibiotics, probiotics, prebiotics, polyphenols and faecal microbiota transplantation.
Keywords: INTESTINAL BACTERIA.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
Similar articles
-
Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?Curr Clin Pharmacol. 2020;15(3):216-233. doi: 10.2174/1574884715666200312100237. Curr Clin Pharmacol. 2020. PMID: 32164516 Review.
-
Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.Intern Med J. 2016 Mar;46(3):266-73. doi: 10.1111/imj.13003. Intern Med J. 2016. PMID: 26968595 Review.
-
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.Nutrients. 2021 May 23;13(6):1780. doi: 10.3390/nu13061780. Nutrients. 2021. PMID: 34071065 Free PMC article. Review.
-
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.Proc Nutr Soc. 2007 Aug;66(3):307-15. doi: 10.1017/S0029665107005563. Proc Nutr Soc. 2007. PMID: 17637082 Review.
-
[The role of gut microbiota in chronic liver diseases, and treatment possibilities].Orv Hetil. 2018 Sep;159(36):1465-1474. doi: 10.1556/650.2018.31178. Orv Hetil. 2018. PMID: 30175608 Review. Hungarian.
Cited by
-
Role of Gut Microbiome in Cancer Treatment.Indian J Microbiol. 2024 Sep;64(3):1310-1325. doi: 10.1007/s12088-024-01340-4. Epub 2024 Jun 27. Indian J Microbiol. 2024. PMID: 39282183
-
The mediating role of metabolites between gut microbiome and Hirschsprung disease: a bidirectional two-step Mendelian randomization study.Front Pediatr. 2024 Aug 27;12:1371933. doi: 10.3389/fped.2024.1371933. eCollection 2024. Front Pediatr. 2024. PMID: 39258147 Free PMC article.
-
Broadening horizons: intestinal microbiota as a novel biomarker and potential treatment for hypertensive disorders of pregnancy.Front Cell Infect Microbiol. 2024 Aug 22;14:1446580. doi: 10.3389/fcimb.2024.1446580. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39239636 Free PMC article. Review.
-
CAIM: coverage-based analysis for identification of microbiome.Brief Bioinform. 2024 Jul 25;25(5):bbae424. doi: 10.1093/bib/bbae424. Brief Bioinform. 2024. PMID: 39222062 Free PMC article.
-
Mechanism of probiotics in the intervention of colorectal cancer: a review.World J Microbiol Biotechnol. 2024 Aug 20;40(10):306. doi: 10.1007/s11274-024-04112-w. World J Microbiol Biotechnol. 2024. PMID: 39160377 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources